Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy
Zhigong Wei(North Sichuan Medical University), Jianghong Xiao(Sichuan University), Xingchen Peng(Sichuan University), Ruidan Li(Sichuan University), Jingjing Wang(State Key Laboratory of Biotherapy), Lianlian Yang(Sichuan University), Xiaoli Mu(Sichuan University), Ling He(Sichuan University), Yan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zheran Liu(Sichuan University)
Cited by 12
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Comprehensive analysis of prognostic immune‐related genes in the tumor microenvironment of cutaneous melanoma
|Journal of Cellular Physiology|2019|111
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
|Cardiovascular Diabetology|2024|72